Supporting innovative projects for ovarian cancer research
Developmental Research Program (DRP)
['FUNDING_OTHER'] · DANA-FARBER CANCER INST · NIH-10895327
This program is all about supporting new and creative research ideas to improve the understanding and treatment of ovarian cancer, especially encouraging diverse researchers to get involved, so we can find better ways to help those affected by this condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DANA-FARBER CANCER INST (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10895327 on ClinicalTrials.gov |
What this research studies
This program aims to foster high-risk, high-potential pilot projects focused on ovarian cancer within the Dana-Farber/Harvard Cancer Center. It encourages innovative research approaches that leverage new opportunities and resources available through the center. The program is designed to support projects that show promise in advancing the understanding and treatment of ovarian cancer, with a particular emphasis on inclusivity for minority and female researchers. Successful projects may transition into full-scale studies with additional support.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with ovarian cancer or those at high risk for developing the disease.
Not a fit: Patients with non-ovarian cancers or those not diagnosed with any cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in the diagnosis and treatment of ovarian cancer.
How similar studies have performed: Other research initiatives focused on innovative approaches to cancer treatment have shown promising results, indicating potential for success in this area as well.
Where this research is happening
BOSTON, UNITED STATES
- DANA-FARBER CANCER INST — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MATULONIS, URSULA ANNE — DANA-FARBER CANCER INST
- Study coordinator: MATULONIS, URSULA ANNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center